Dual-energy CT (DECT) is revolutionizing cancer research by offering enhanced imaging capabilities. By employing two different energy levels of X-rays, DECT provides superior tissue characterization, enabling precise tumor detection and characterization. This technology allows researchers to distinguish between different tissue types, such as identifying malignant masses from surrounding healthy tissue with greater accuracy. DECT also aids in evaluating tumor vascularity and assessing treatment response by detecting subtle changes in tissue composition. Moreover, DECT enables simultaneous imaging of both anatomy and function, facilitating comprehensive cancer assessment in a single scan session. Its ability to provide detailed information about tumor morphology and physiology makes DECT a valuable tool in oncological research, promising improved diagnostic accuracy and treatment outcomes for cancer patients.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States